European Healthtech startup funding raised during H2 2023.
In H2 2023, 222 European Healthtech companies raised a combined €4.6B across 226 funding rounds, up 10.7% versus H2 2022. Netherlands led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Philips | Other | Aug 2023 | €2.6B |
| Compass Pathways | Other | Aug 2023 | €261M |
| CMR Surgical | Other | Sep 2023 | €154M |
| Aqemia | Other | Dec 2023 |
15 exits · €6.3B disclosed.
| Abcam | Acquisition | Aug 2023 | €5.2B |
| MedAlliance | Acquisition | Oct 2023 | €1.1B |
| €129M |
| Agomab Therapeutics | Series C | Oct 2023 | €95M |
| EyeBiotech | Series A | Nov 2023 | €61M |
| Neko Health | Series A | Jul 2023 | €60M |
| Corti | Series B | Sep 2023 | €56M |
| MinervaX | Other | Oct 2023 | €54M |
| Causaly | Series B | Jul 2023 | €54M |
| Lightcast Discovery | Series B | Aug 2023 | €45M |
| In Ovo | Debt | Nov 2023 | €40M |
| Automata Technologies | Other | Oct 2023 | €38M |
| MYCB1 | Other | Sep 2023 | €31M |
| Bactolife | Series A | Aug 2023 | €30M |